AMGEN INC

AMGN CIK: 318154 Manufacturing Chemicals & Allied Products

THOUSAND OAKS, CA

Financials

Price History

Market Data

Market Cap	176.92B
P/E Ratio	23.05
P/B Ratio	20.43
EPS	14.24
Dividend Yield	2.94%
D/E Ratio	-
Current Ratio	1.14
Currency	USD

Key Financial Metrics

36.75B

Revenue

7.71B

Net Income

14.24

EPS (Diluted)

11.97B

Free Cash Flow

Profitability

Gross Margin 67.2%

Operating Margin 24.7%

Net Profit Margin 21.0%

EBITDA 18.36B

Returns & Efficiency

Return on Assets (ROA) 8.5%

Return on Equity (ROE) 89.1%

Dividend Yield 2.94%

EPS 14.24

Financial Health

Total Assets 90.59B

Total Debt 54.60B

Debt to Equity -

Current Ratio 1.14

Insider Trading Last 12 months

Buys

Sells

Insiders

Quick Access Filings

10-K

Annual Report

10-Q

Quarterly Report

8-K

Company Data Library

Earnings Transcripts

Press Releases

Filing Sections

Company Info

Industry	Chemicals & Allied Products
HQ	THOUSAND OAKS, CA
Fiscal Year	2025

Peers

GILEAD SCIENCES INC

GILD

166.13B

P/E: --

GILEAD SCIENCES, INC.

GILD

166.13B

P/E: --

BIOGEN IDEC INC.

BIIB

27.90B

P/E: --

BIOGEN INC.

BIIB

27.90B

P/E: --

REVOLUTION MEDICINES, INC.

RVMD

19.11B

P/E: --

MODERNA, INC.

MRNA

18.38B

P/E: --

Moderna, Inc.

MRNA

18.38B

P/E: --

NEUROCRINE BIOSCIENCES INC

NBIX

13.53B

P/E: 32.5

Quick Links

Full Financials Advanced Charts Filings

Financial Statistics

Valuation

Market Cap$176.92B

P/E Ratio (TTM)23.0

Price to Book20.43

EV/Revenue-

EV/EBITDA-

Profitability

Gross Margin67.2%

Operating Margin24.7%

Net Margin21.0%

ROE89.1%

ROA8.5%

Leverage & Liquidity

Debt to Equity-

Current Ratio1.14

Total Debt$54.60B

Total Assets$90.59B

Stockholders' Equity$8.66B

Income Statement (FY 2025)

Revenue$36.75B

Gross Profit$24.71B

Operating Income$9.08B

Net Income$7.71B

EPS (Diluted)$14.24

Cash Flow (FY 2025)

Free Cash Flow$11.97B

Cash & Equivalents$9.13B

Revenue Growth10.0%

SEC Filings by Category

Financial Reports

Current Event Reports

Insider Trading Activity

Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0

Insider	Title	Date	Type	Shares	Price	Value

Company Information

Business Address	ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320
Phone	(805)447-1000
Incorporated	DE, US
EIN	953540776
Fiscal Year End	1231
Shares Outstanding	539.07M
Stockholders' Equity	$8.66B
Cash & Equivalents	$9.13B

Recent Filings View All

144 Proposed Sale Notice

Notice of proposed sale of securities

Filed: 2026-05-04

Local

8-K Current Report

Report of material events (acquisitions, earnings, executive changes)

Filed: 2026-04-30

Local

SCHEDULE 13G Passive Ownership Report

Schedule 13G - passive beneficial ownership

Filed: 2026-04-29

Local

8-K Current Report

Report of material events (acquisitions, earnings, executive changes)

Filed: 2026-04-22

Local

DEFA14A Additional Proxy Materials

Additional definitive proxy soliciting materials

Filed: 2026-04-21

Local

DEFA14A Additional Proxy Materials

Additional definitive proxy soliciting materials

Filed: 2026-04-15

Local

DEFA14A Additional Proxy Materials

Additional definitive proxy soliciting materials

Filed: 2026-04-07

Local

DEF 14A Definitive Proxy Statement

Official proxy statement for shareholder voting

Filed: 2026-04-07

Local

ARS Annual Report to Shareholders

Annual report furnished to shareholders

Filed: 2026-03-31

Local

SCHEDULE 13G/A Amended Schedule 13G

Amendment to Schedule 13G

Filed: 2026-03-26

Local

4 Insider Transaction Report